Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke

Naoki Tajiri, Sandra Acosta, Gabriel S. Portillo-Gonzales, Daniela Aguirre, Stephanny Reyes, Diego Lozano, Mibel Pabon, Ike Dela Peña, Xunming Ji, Takao Yasuhara, Isao Date, Marianna A. Solomita, Ivana Antonucci, Liborio Stuppia, Yuji Kaneko, Cesar V. Borlongan

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Accumulating preclinical evidence suggests the use of amnion as a source of stem cells for investigations of basic science concepts related to developmental cell biology, but also for stem cells' therapeutic applications in treating human disorders. We previously reported isolation of viable rat amniotic fluid-derived stem (AFS) cells. Subsequently, we recently reported the therapeutic benefits of intravenous transplantation of AFS cells in a rodent model of ischemic stroke. Parallel lines of investigations have provided safety and efficacy of stem cell therapy for treating stroke and other neurological disorders. This review article highlights the need for investigations of mechanisms underlying AFS cells' therapeutic benefits and discusses lab-to-clinic translational gating items in an effort to optimize the clinical application of the cell transplantation for stroke.

Original languageEnglish
Article number227
JournalFrontiers in Cellular Neuroscience
Volume8
Issue numberAUG
DOIs
Publication statusPublished - Aug 13 2014

Fingerprint

Amniotic Fluid
Stem Cells
Transplantation
Stroke
Therapeutics
Developmental Biology
Amnion
Cell Transplantation
Cell- and Tissue-Based Therapy
Nervous System Diseases
Cell Biology
Rodentia
Safety

Keywords

  • Cerebral ischemia
  • Neural stem/progenitor cells
  • Neurogenesis
  • Neurotrophic factors
  • Regenerative medicine

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Tajiri, N., Acosta, S., Portillo-Gonzales, G. S., Aguirre, D., Reyes, S., Lozano, D., ... Borlongan, C. V. (2014). Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke. Frontiers in Cellular Neuroscience, 8(AUG), [227]. https://doi.org/10.3389/fncel.2014.00227

Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke. / Tajiri, Naoki; Acosta, Sandra; Portillo-Gonzales, Gabriel S.; Aguirre, Daniela; Reyes, Stephanny; Lozano, Diego; Pabon, Mibel; Peña, Ike Dela; Ji, Xunming; Yasuhara, Takao; Date, Isao; Solomita, Marianna A.; Antonucci, Ivana; Stuppia, Liborio; Kaneko, Yuji; Borlongan, Cesar V.

In: Frontiers in Cellular Neuroscience, Vol. 8, No. AUG, 227, 13.08.2014.

Research output: Contribution to journalArticle

Tajiri, N, Acosta, S, Portillo-Gonzales, GS, Aguirre, D, Reyes, S, Lozano, D, Pabon, M, Peña, ID, Ji, X, Yasuhara, T, Date, I, Solomita, MA, Antonucci, I, Stuppia, L, Kaneko, Y & Borlongan, CV 2014, 'Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke', Frontiers in Cellular Neuroscience, vol. 8, no. AUG, 227. https://doi.org/10.3389/fncel.2014.00227
Tajiri, Naoki ; Acosta, Sandra ; Portillo-Gonzales, Gabriel S. ; Aguirre, Daniela ; Reyes, Stephanny ; Lozano, Diego ; Pabon, Mibel ; Peña, Ike Dela ; Ji, Xunming ; Yasuhara, Takao ; Date, Isao ; Solomita, Marianna A. ; Antonucci, Ivana ; Stuppia, Liborio ; Kaneko, Yuji ; Borlongan, Cesar V. / Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke. In: Frontiers in Cellular Neuroscience. 2014 ; Vol. 8, No. AUG.
@article{111cd16429354aa89296f11e6b009c97,
title = "Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke",
abstract = "Accumulating preclinical evidence suggests the use of amnion as a source of stem cells for investigations of basic science concepts related to developmental cell biology, but also for stem cells' therapeutic applications in treating human disorders. We previously reported isolation of viable rat amniotic fluid-derived stem (AFS) cells. Subsequently, we recently reported the therapeutic benefits of intravenous transplantation of AFS cells in a rodent model of ischemic stroke. Parallel lines of investigations have provided safety and efficacy of stem cell therapy for treating stroke and other neurological disorders. This review article highlights the need for investigations of mechanisms underlying AFS cells' therapeutic benefits and discusses lab-to-clinic translational gating items in an effort to optimize the clinical application of the cell transplantation for stroke.",
keywords = "Cerebral ischemia, Neural stem/progenitor cells, Neurogenesis, Neurotrophic factors, Regenerative medicine",
author = "Naoki Tajiri and Sandra Acosta and Portillo-Gonzales, {Gabriel S.} and Daniela Aguirre and Stephanny Reyes and Diego Lozano and Mibel Pabon and Pe{\~n}a, {Ike Dela} and Xunming Ji and Takao Yasuhara and Isao Date and Solomita, {Marianna A.} and Ivana Antonucci and Liborio Stuppia and Yuji Kaneko and Borlongan, {Cesar V.}",
year = "2014",
month = "8",
day = "13",
doi = "10.3389/fncel.2014.00227",
language = "English",
volume = "8",
journal = "Frontiers in Cellular Neuroscience",
issn = "1662-5102",
publisher = "Frontiers Research Foundation",
number = "AUG",

}

TY - JOUR

T1 - Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke

AU - Tajiri, Naoki

AU - Acosta, Sandra

AU - Portillo-Gonzales, Gabriel S.

AU - Aguirre, Daniela

AU - Reyes, Stephanny

AU - Lozano, Diego

AU - Pabon, Mibel

AU - Peña, Ike Dela

AU - Ji, Xunming

AU - Yasuhara, Takao

AU - Date, Isao

AU - Solomita, Marianna A.

AU - Antonucci, Ivana

AU - Stuppia, Liborio

AU - Kaneko, Yuji

AU - Borlongan, Cesar V.

PY - 2014/8/13

Y1 - 2014/8/13

N2 - Accumulating preclinical evidence suggests the use of amnion as a source of stem cells for investigations of basic science concepts related to developmental cell biology, but also for stem cells' therapeutic applications in treating human disorders. We previously reported isolation of viable rat amniotic fluid-derived stem (AFS) cells. Subsequently, we recently reported the therapeutic benefits of intravenous transplantation of AFS cells in a rodent model of ischemic stroke. Parallel lines of investigations have provided safety and efficacy of stem cell therapy for treating stroke and other neurological disorders. This review article highlights the need for investigations of mechanisms underlying AFS cells' therapeutic benefits and discusses lab-to-clinic translational gating items in an effort to optimize the clinical application of the cell transplantation for stroke.

AB - Accumulating preclinical evidence suggests the use of amnion as a source of stem cells for investigations of basic science concepts related to developmental cell biology, but also for stem cells' therapeutic applications in treating human disorders. We previously reported isolation of viable rat amniotic fluid-derived stem (AFS) cells. Subsequently, we recently reported the therapeutic benefits of intravenous transplantation of AFS cells in a rodent model of ischemic stroke. Parallel lines of investigations have provided safety and efficacy of stem cell therapy for treating stroke and other neurological disorders. This review article highlights the need for investigations of mechanisms underlying AFS cells' therapeutic benefits and discusses lab-to-clinic translational gating items in an effort to optimize the clinical application of the cell transplantation for stroke.

KW - Cerebral ischemia

KW - Neural stem/progenitor cells

KW - Neurogenesis

KW - Neurotrophic factors

KW - Regenerative medicine

UR - http://www.scopus.com/inward/record.url?scp=84939448443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939448443&partnerID=8YFLogxK

U2 - 10.3389/fncel.2014.00227

DO - 10.3389/fncel.2014.00227

M3 - Article

AN - SCOPUS:84939448443

VL - 8

JO - Frontiers in Cellular Neuroscience

JF - Frontiers in Cellular Neuroscience

SN - 1662-5102

IS - AUG

M1 - 227

ER -